Liqun Chen

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi et al. · Annals of Oncology · 2017 · 576 citations · Full text

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa, Shukui Qin, Baek‐Yeol Ryoo et al. · Annals of Oncology · 2018 · 243 citations · Full text

Oncology, Hepatology, Cancer Management +8

A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma

Amitesh Roy, S. R. Park, David Cunningham et al. · Annals of Oncology · 2013 · 121 citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Gastro-oesophageal Junction Adenocarcinoma +10

Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

Ting‐Chang Chang, H. Shiah, Kun‐Huei Yeh et al. · Cancer Chemotherapy and Pharmacology · 2015 · 96 citations · Full text

Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer

Suparat Charoenfuprasert, Y. Y. Yang, Y. C. Lee et al. · Oncogene · 2011 · 45 citations

Medicine, Pathology, Cancer Genomics +7